Silverfin false false 31/08/2025 01/09/2024 31/08/2025 J T Gape 07/08/2018 N Hancock 30/09/2024 16/10/2019 30 January 2026 The principal activity of the year was that of wholesale and manufacturing of health supplements. 11504167 2025-08-31 11504167 bus:Director1 2025-08-31 11504167 bus:Director2 2025-08-31 11504167 2024-08-31 11504167 core:CurrentFinancialInstruments 2025-08-31 11504167 core:CurrentFinancialInstruments 2024-08-31 11504167 core:ShareCapital 2025-08-31 11504167 core:ShareCapital 2024-08-31 11504167 core:SharePremium 2025-08-31 11504167 core:SharePremium 2024-08-31 11504167 core:RetainedEarningsAccumulatedLosses 2025-08-31 11504167 core:RetainedEarningsAccumulatedLosses 2024-08-31 11504167 core:OfficeEquipment 2024-08-31 11504167 core:ComputerEquipment 2024-08-31 11504167 core:OfficeEquipment 2025-08-31 11504167 core:ComputerEquipment 2025-08-31 11504167 bus:OrdinaryShareClass1 2025-08-31 11504167 2024-09-01 2025-08-31 11504167 bus:FilletedAccounts 2024-09-01 2025-08-31 11504167 bus:SmallEntities 2024-09-01 2025-08-31 11504167 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 11504167 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 11504167 bus:Director1 2024-09-01 2025-08-31 11504167 bus:Director2 2024-09-01 2025-08-31 11504167 core:OfficeEquipment core:TopRangeValue 2024-09-01 2025-08-31 11504167 core:ComputerEquipment core:TopRangeValue 2024-09-01 2025-08-31 11504167 2023-09-01 2024-08-31 11504167 core:OfficeEquipment 2024-09-01 2025-08-31 11504167 core:ComputerEquipment 2024-09-01 2025-08-31 11504167 bus:OrdinaryShareClass1 2024-09-01 2025-08-31 11504167 bus:OrdinaryShareClass1 2023-09-01 2024-08-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 11504167 (England and Wales)

APE NUTRITION LTD

Unaudited Financial Statements
For the financial year ended 31 August 2025
Pages for filing with the registrar

APE NUTRITION LTD

Unaudited Financial Statements

For the financial year ended 31 August 2025

Contents

APE NUTRITION LTD

STATEMENT OF FINANCIAL POSITION

As at 31 August 2025
APE NUTRITION LTD

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 August 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 3 2,716 1,582
2,716 1,582
Current assets
Stocks 4 417,572 103,272
Debtors 5 114,662 45,816
Cash at bank and in hand 239,711 111,941
771,945 261,029
Creditors: amounts falling due within one year 6 ( 371,572) ( 145,570)
Net current assets 400,373 115,459
Total assets less current liabilities 403,089 117,041
Net assets 403,089 117,041
Capital and reserves
Called-up share capital 7 31 17
Share premium account 270,146 164,975
Profit and loss account 132,912 ( 47,951 )
Total shareholders' funds 403,089 117,041

For the financial year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Ape Nutrition Ltd (registered number: 11504167) were approved and authorised for issue by the Director. They were signed on its behalf by:

J T Gape
Director

30 January 2026

APE NUTRITION LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 August 2025
APE NUTRITION LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 August 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Ape Nutrition Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the company's registered office is 35 Ballards Lane, London, N3 1XW, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Statement of Financial Position date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Office equipment 3 years straight line
Computer equipment 3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

The Company only enters into basic financial instruments and transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to and from related parties and investments in non-puttable ordinary shares.

Financial assets
Basic financial assets, including trade and other debtors, and amounts due from related companies, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Such assets are subsequently carried at amortised cost using the effective interest method.

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in the Statement of Income and Retained Earnings/Statement of Comprehensive Income.

Financial liabilities
Basic financial liabilities, including trade and other creditors and accruals, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the company during the year, including the director 2 1

3. Tangible assets

Office equipment Computer equipment Total
£ £ £
Cost
At 01 September 2024 0 2,590 2,590
Additions 149 2,255 2,404
At 31 August 2025 149 4,845 4,994
Accumulated depreciation
At 01 September 2024 0 1,008 1,008
Charge for the financial year 21 1,249 1,270
At 31 August 2025 21 2,257 2,278
Net book value
At 31 August 2025 128 2,588 2,716
At 31 August 2024 0 1,582 1,582

4. Stocks

2025 2024
£ £
Stocks 417,572 103,272

5. Debtors

2025 2024
£ £
Trade debtors 6,552 6,526
Other debtors 108,110 39,290
114,662 45,816

6. Creditors: amounts falling due within one year

2025 2024
£ £
Trade creditors 154,543 65,920
Taxation and social security 136,221 42,087
Other creditors 80,808 37,563
371,572 145,570

7. Called-up share capital and reserves

2025 2024
£ £
Allotted, called-up and fully-paid
314,473 Ordinary shares of £ 0.0001 each (2024: 167,366 shares of £ 0.0001 each) 31 17
Presented as follows:
Called-up share capital presented as equity 31 17

During the year 147,107 Ordinary shares of £0.0001 each were issued for cash consideration. After the financial year end, 62,928 Ordinary shares of £0.0001 were issued for cash consideration.